Article Details

Matinas BioPharma Faces Uncertain Future After Halting MAT2203 Development

Retrieved on: 2024-11-15 18:05:24

Tags for this article:

Click the tags to see associated articles and topics

Matinas BioPharma Faces Uncertain Future After Halting MAT2203 Development. View article details on hiswai:

Excerpt

Matinas BioPharma Holdings (MTNB) has disclosed a new risk, in the Innovation / R&D category. Matinas BioPharma Holdings faces significant ...

Article found on: www.tipranks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo